Sea Crest Wealth Management, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Sea Crest Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$5.4 - $15.5 $2,754 - $7,905	-510 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$2.89 - $7.91 $28 - $79	10 Added 2.0%	510 $2,000
Q1 2018 Apr 20, 2018	SELL	$8.49 - $13.46 $2,547 - $4,038	-300 Reduced 37.5%	500 $4,000
Q4 2017 Feb 02, 2018	BUY	$8.69 - $14.59 $6,952 - $11,672	800	800 $10,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.